Clinical Research Study for Non-Small Cell Lung Cancer
The UNC Lineberger Comprehensive Cancer Center has been selected to participate in a novel clinical trial testing a specially prepared vaccine's ability to prevent recurrences in patients undergoing surgery for non-small cell lung cancer.
The trial's principle investigator is Dr. Richard H. Feins, a member of the thoracic surgery section at UNC, and will involve patients whose resected tumors test positive for the MAGE antigen. The presence of the MAGE antigen in non-small cell lung cancers has been shown to result in lower cure rates.
UNC seeks study participants 18 years and older with non-small cell lung cancer in stage IB, II or IIIA who are candidates for surgery.
For more information, contact Amy Marzinsky, RN, BSN, at 919-966-4432 or amy_marzinsky@med.unc.edu.
Dr. Feins is pictured above using a navigational bronchoscopy to perform a lung biopsy.
UNC Lineberger Experts Highlight Latest in Lung Cancer Research and Treatment
Watch video as Dr. Ben Haithcock discusses common signs and symptoms of lung cancer. His remarks cover current clinical research and new therapies at UNC Lineberger and the N.C. Cancer Hospital, including new resection techniques and minimally-invasive surgeries, cyberknife treatment, radio-frequency ablation, genomic-based therapies and bronchoscopy-enabled biopsies.
Watch video as Dr. Neil Hayes discusses the latest genomic analysis, which will enable targeted therapies and the application of personalized medicine to lung cancer.
Watch video of UNC Thoracic Oncology faculty and staff as they talk about lung cancer awareness.
Photo credit: stock.xchng.com.
John Lynch and his wife Glo share their thoughts about John's diagnosis and treatment, clinical trials and why they chose UNC.